Trait Biosciences

Trait Biosciences' Innovative Technologies

Trait Biosciences has developed groundbreaking technologies that convert water-insoluble cannabinoids into water-soluble materials. This innovation is significant because it enhances the bioavailability and efficacy of cannabinoid products, making them more accessible and effective for consumers. Their suite of proprietary technology platforms is tailored specifically for the hemp industry, addressing key challenges in cannabinoid production and formulation. Notably, Trait Biosciences is the first company to develop truly water-soluble cannabinoid extracts, setting a new standard in the market and offering a competitive edge in product development.

Trait Biosciences' Funding and Investors

Trait Biosciences recently closed a significant funding round led by Btomorrow Ventures and Gotham Green Partners. This infusion of capital is a testament to the company's innovative approach and market potential. The funding will support further research and development, scaling of production capabilities, and expansion into new markets. Investors like Btomorrow Ventures and Gotham Green Partners bring not only financial resources but also strategic guidance and industry connections, positioning Trait Biosciences for robust growth in the burgeoning global cannabinoid market, projected to reach $45 billion by 2024.

Trait Biosciences' State-of-the-Art Lab

Trait Biosciences operates in a cutting-edge, 30,000 square foot open concept lab. This facility is equipped with advanced capabilities in microbiology, genetics, biochemistry, chemistry, and analytical testing. The lab's state-of-the-art infrastructure enables high-precision research and development, facilitating the discovery and optimization of novel cannabinoid production techniques. This environment supports a collaborative approach to scientific innovation, fostering breakthroughs in areas such as fermentation, metabolic engineering, bioinformatics, and plant secondary metabolism.

Trait Biosciences' Patent for Increased Cannabinoid Production

Trait Biosciences holds a patent for a proprietary process that can increase cannabinoid production by up to 200%. This patented technology represents a significant advancement in cannabinoid biosynthesis, offering the potential for more efficient and cost-effective production methods. By enhancing yield, Trait Biosciences can meet growing market demands while maintaining high standards of quality and consistency. This innovation not only benefits the company commercially but also contributes to the broader field of cannabinoid research and application.

Trait Biosciences in the Global Cannabinoid Market

With the global cannabinoid market projected to reach $45 billion by 2024, Trait Biosciences is strategically positioned to be a key player. The company's focus on bio-molecular science and transformative technologies addresses critical industry needs, from improving bioavailability to increasing production efficiency. Their innovative solutions and state-of-the-art facilities enable them to stay ahead in a competitive market. As consumer demand for cannabinoid products continues to rise, Trait Biosciences' technological advancements and strategic investments are poised to drive significant growth and industry leadership.